A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval
OBJECTIVE: To evaluate the effects of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion on hemodynamic parameters, pain, sedation, and recovery score during oocyte retrieval. METHODS: Sixty-nine women were scheduled for oocyte retrieval. Target-...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier España
2011-01-01
|
| Series: | Clinics |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000500017 |
| _version_ | 1811229767083491328 |
|---|---|
| author | Demet Coskun Berrin Gunaydin Ayca Tas Gozde Inan Hulya Celebi Kadir Kaya |
| author_facet | Demet Coskun Berrin Gunaydin Ayca Tas Gozde Inan Hulya Celebi Kadir Kaya |
| author_sort | Demet Coskun |
| collection | DOAJ |
| description | OBJECTIVE: To evaluate the effects of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion on hemodynamic parameters, pain, sedation, and recovery score during oocyte retrieval. METHODS: Sixty-nine women were scheduled for oocyte retrieval. Target-controlled propofol infusion at an effectsite concentration of 1.5 μg/mL was instituted. The patients were randomly allocated to receive remifentanil at an effect-site concentration of either 1.5 (group I, n = 23), 2 (group II, n = 23) or 2.5 ng/mL (group III, n = 23). Hemodynamic variables, sedation, pain, the Aldrete recovery score, and side effects were recorded. RESULTS: Hemodynamic variables, sedation and pain scores and the number of patients with the maximum Aldrete recovery score 10 min after the procedure were comparable among the groups. The number of patients in group III with the maximum Aldrete recovery score 5 min after the procedure was significantly lower than that in groups I and II. One patient in group II and one patient in group III suffered from nausea. CONCLUSION: Similar pain-free conscious sedation conditions without significant changes in hemodynamic parameters were provided by all three protocols. However, target controlled infusion of remifentanil at 1.5 or 2 ng/mL proved superior at providing early recovery compared to 2.5 ng/mL. |
| first_indexed | 2024-04-12T10:19:37Z |
| format | Article |
| id | doaj.art-db1d06df6b654ca28a7c3722d81285ce |
| institution | Directory Open Access Journal |
| issn | 1807-5932 1980-5322 |
| language | English |
| last_indexed | 2024-04-12T10:19:37Z |
| publishDate | 2011-01-01 |
| publisher | Elsevier España |
| record_format | Article |
| series | Clinics |
| spelling | doaj.art-db1d06df6b654ca28a7c3722d81285ce2022-12-22T03:37:08ZengElsevier EspañaClinics1807-59321980-53222011-01-0166581181510.1590/S1807-59322011000500017A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrievalDemet CoskunBerrin GunaydinAyca TasGozde InanHulya CelebiKadir KayaOBJECTIVE: To evaluate the effects of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion on hemodynamic parameters, pain, sedation, and recovery score during oocyte retrieval. METHODS: Sixty-nine women were scheduled for oocyte retrieval. Target-controlled propofol infusion at an effectsite concentration of 1.5 μg/mL was instituted. The patients were randomly allocated to receive remifentanil at an effect-site concentration of either 1.5 (group I, n = 23), 2 (group II, n = 23) or 2.5 ng/mL (group III, n = 23). Hemodynamic variables, sedation, pain, the Aldrete recovery score, and side effects were recorded. RESULTS: Hemodynamic variables, sedation and pain scores and the number of patients with the maximum Aldrete recovery score 10 min after the procedure were comparable among the groups. The number of patients in group III with the maximum Aldrete recovery score 5 min after the procedure was significantly lower than that in groups I and II. One patient in group II and one patient in group III suffered from nausea. CONCLUSION: Similar pain-free conscious sedation conditions without significant changes in hemodynamic parameters were provided by all three protocols. However, target controlled infusion of remifentanil at 1.5 or 2 ng/mL proved superior at providing early recovery compared to 2.5 ng/mL.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000500017Target-Controlled InfusionPropofolRemifentanilOocyte RetrievalSedation |
| spellingShingle | Demet Coskun Berrin Gunaydin Ayca Tas Gozde Inan Hulya Celebi Kadir Kaya A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval Clinics Target-Controlled Infusion Propofol Remifentanil Oocyte Retrieval Sedation |
| title | A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval |
| title_full | A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval |
| title_fullStr | A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval |
| title_full_unstemmed | A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval |
| title_short | A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval |
| title_sort | comparison of three different target controlled remifentanil infusion rates during target controlled propofol infusion for oocyte retrieval |
| topic | Target-Controlled Infusion Propofol Remifentanil Oocyte Retrieval Sedation |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000500017 |
| work_keys_str_mv | AT demetcoskun acomparisonofthreedifferenttargetcontrolledremifentanilinfusionratesduringtargetcontrolledpropofolinfusionforoocyteretrieval AT berringunaydin acomparisonofthreedifferenttargetcontrolledremifentanilinfusionratesduringtargetcontrolledpropofolinfusionforoocyteretrieval AT aycatas acomparisonofthreedifferenttargetcontrolledremifentanilinfusionratesduringtargetcontrolledpropofolinfusionforoocyteretrieval AT gozdeinan acomparisonofthreedifferenttargetcontrolledremifentanilinfusionratesduringtargetcontrolledpropofolinfusionforoocyteretrieval AT hulyacelebi acomparisonofthreedifferenttargetcontrolledremifentanilinfusionratesduringtargetcontrolledpropofolinfusionforoocyteretrieval AT kadirkaya acomparisonofthreedifferenttargetcontrolledremifentanilinfusionratesduringtargetcontrolledpropofolinfusionforoocyteretrieval AT demetcoskun comparisonofthreedifferenttargetcontrolledremifentanilinfusionratesduringtargetcontrolledpropofolinfusionforoocyteretrieval AT berringunaydin comparisonofthreedifferenttargetcontrolledremifentanilinfusionratesduringtargetcontrolledpropofolinfusionforoocyteretrieval AT aycatas comparisonofthreedifferenttargetcontrolledremifentanilinfusionratesduringtargetcontrolledpropofolinfusionforoocyteretrieval AT gozdeinan comparisonofthreedifferenttargetcontrolledremifentanilinfusionratesduringtargetcontrolledpropofolinfusionforoocyteretrieval AT hulyacelebi comparisonofthreedifferenttargetcontrolledremifentanilinfusionratesduringtargetcontrolledpropofolinfusionforoocyteretrieval AT kadirkaya comparisonofthreedifferenttargetcontrolledremifentanilinfusionratesduringtargetcontrolledpropofolinfusionforoocyteretrieval |